Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Abuse-deterring technology developer Egalet nets $53.9mm in IPO

Executive Summary

UK biotech Egalet Corp. netted $53.9mm in its US initial public offering. The company sold 4.8mm shares (including the overallotment; and more than the 3.5mm planned) at $12, the mid-point of its $11-13 price range.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies